Study Title: Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003
 

  • Status: Closed to Accrual at:
    • University of Illinois Cancer Center
    • Indiana University Melvin and Bren Simon Cancer Center
    • Holden Comprehensive Cancer Center, University of Iowa
    • University of Michigan Comprehensive Cancer Center
    • University of Minnesota Masonic Cancer Center
    • Michigan State University Breslin Cancer Center
    • Fred & Pamela Buffett Cancer Center (University of Nebraska)
    • Penn State Cancer Institute
    • Rutgers Cancer Institute of New Jersey
    • University of Wisconsin Carbone Cancer Center
  • Publications:
    • Phase Ib poster: 2016 Genitourinary Cancers Symposium (See abstract)
  • Description: clinicaltrials.gov: NCT02348008